GBSI BioPolicy Summit 2017 Explores Technologies for Improved Preclinical Research Reproducibility – October 16

Home / Community Blog / GBSI BioPolicy Summit 2017 Explores Technologies for Improved Preclinical Research Reproducibility – October 16

Community Blog

GBSI BioPolicy Summit 2017 Explores Technologies for Improved Preclinical Research Reproducibility – October 16

Global Biological Standards Institute’s 3rd annual BioPolicy Summit: “Improving Reproducibility of Research Through Digital Tools, Technologies and Laboratory Automation,” will bring a diverse and interdisciplinary group of participants together—biologists, tech programmers, instrumentation manufacturers, the maker community, journals, and funders—to explore how the newest life science research tools and technology can enhance reproducibility in preclinical research.  The meeting will be held on October 16, 2017 at the Mission Bay Conference Center in San Francisco.  

Top scientists and tech inventors will demonstrate their latest innovations, such as affordable miniaturized robotics advancements, new systems to gather, edit, share, and improve information, and detailed protocols that will revolutionize the way science is done. Scientists, researchers, and academicians will offer insight into organizational strategies and tools needed to capture the benefits of automation and steer discussion about how these innovations, along with traditional scientific methods and expertise, will revolutionize and ultimately advance treatments and cures.

WHEN: October 16, 2017, 8:30 a.m. – 8:00 p.m. PST

WHERE:  Mission Bay Conference Center, UCSF, 1675 Owens St., #251, San Francisco

The nature of the laboratory is fundamentally changing. GBSI’s BioPolicy Summit will yield important insights into the laboratory of the future, including specific new technologies that will revolutionize research and strategies to propel innovation forward and make research more reproducible. The meeting builds upon others held by GBSI since 2013 to convene stakeholders in cell authentication, antibody validation, and other priorities undertaken by the life sciences research community to shore up the reproducibility crisis. 

 

Leave a Comment

*